Filing Flows › agilon health (AGL) › Q3 2026 › vs Q2 2026
agilon health (AGL) Q3 2026 vs Q2 2026 (quarter over quarter)
agilon health's revenue rose $24.7M (+2%) from $1.5B in Q2 2026 to $1.5B in Q3 2026. Operating margin 1.6% against 0.8% (+0.8 pts).
agilon health, Q3 2026: revenue $1.5B (+6% year over year), operating margin 1.6%, net earnings $34.9M, operating cash flow $49.9M. The chart draws each line against Q2 2026, the increases inside each band.
Margins
| Q3 2026 | Q2 2026 | Change | |
|---|---|---|---|
| Operating margin | 1.6% | 0.8% | +0.8 pts |
| Net margin | 2.3% | 1.2% | +1.1 pts |
| Free cash flow margin | 3.1% | -4.1% | +7.1 pts |
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $1.5B | $1.5B | $24.7M | +2% |
| Other income, net | $14.8M | $5.8M | $9.0M | +155% |
| Operating profit | $24.1M | $11.8M | $12.3M | +105% |
| Costs & expenses | $1.5B | $1.5B | $12.4M | +0.8% |
| Pre-tax earnings | $38.9M | $17.6M | $21.3M | +121% |
| General & admin | $67.1M | $88.5M | −$21.4M | -24% |
| Other operating costs | $1.4B | $1.4B | $33.8M | +2% |
| Net earnings | $34.9M | $18.0M | $17.0M | +94% |
| Income tax | $4.0M | −$375K | $4.4M | — |
| Depreciation & amortization | $6.7M | $6.9M | −$123K | -2% |
| Share-based compensation | $18.9M | $23.8M | −$5.0M | -21% |
| Working capital & other | $10.6M | $106M | −$95.3M | -90% |
| Operating cash flow | $49.9M | −$57.3M | $107M | — |
| Free cash flow (OCF − capex) | $46.6M | −$60.7M | $107M | — |
| Capital expenditures | $3.3M | $3.4M | −$190K | -6% |
Questions
How much did agilon health's revenue grow quarter over quarter in Q3 2026?
agilon health's revenue rose $24.7M (+2%) from $1.5B in Q2 2026 to $1.5B in Q3 2026. Operating margin 1.6% against 0.8% (+0.8 pts).